Clinical Trial Update: An Interventional Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer [Phase 4]

View source ↗

Summary

A Phase 4 interventional trial evaluating Avastin (bevacizumab) in advanced or metastatic ovarian, fallopian tube, or primary peritoneal cancer has completed; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Ovarian Neoplasms, Peritoneal Neoplasms | Phase 4 | Status: COMPLETED